B16F10-OVA

Export PDF

Strain Information

Cell Line

B16F10-Tg(OVA)Smoc

Cat. NO.

NM-S31A-TG05

Model Description

The B16F10-OVA cell line is a B16F10 cell line with stable and high expression of OVA.

Strain State

Validation of tumorigenic capacity completed

Validation Data

image.png

Figure 1. OVA expression in wild-type B16F10 and B16F10-OVA-Luc cell lines.

image.png


Figure 2. Tumor growth curve of B16F10 and B16F10-OVA-Luc syngeneic model (n=5).

image.png

Figure 3. The expression of OVA in tumors by Western Blot.

Related Strain(s)

CT26-OVA(2)
Cell Line：

CT26-OVA(2)

Cat. NO.：NM-S24A-TM34
E.G7-OVA-hCD24
Cell Line：

E.G7-OVA-hCD24

Cat. NO.：NM-S40-TM01
E.G7-OVA
Cell Line：

E.G7-OVA

Cat. NO.：NM-S40-TM02
Panc02-OVA-Luc
Cell Line：Panc02-OVA-Luc
Cat. NO.：NMC-230050
KPC-OVA-Luc
Cell Line：

KPC-OVA-Luc

Cat. NO.：NMC-230049

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more